home

JS Genetics

Develops and markets proprietary, low cost, high value DNA diagnostic testsfor underserved medical conditions in newborns, children, and adolescents. This focus grew out of the recognition that most genetic tests require blood samples, have longer turn-around times, and are expensive. The Company's principle strategy is to internally develop tests using cheek swabs for sample collection and a PCR based testing platform to bring to market accurate, convenient and cost effective DNA screening tests for adolescents focused in three key areas of developmental disorders:
 

Physical Development:
Turner Syndrome

X Chromosome Abnormality Test (XCAT)

PCR and quantitative pyrosequencing based technology uses a simple cheek swab to accurately determine chromosomal abnormalities. Each kit contains two buccal swabs to collect the DNA and various tests can be performed for each patient sample collected. Kits are sent to healthcare Practitioners free of charge, and patient's insurance will be billed for services rendered.


XCAT-TS: Is a novel molecular genetic test for detection of Classic and Mosaic Turner Syndrome.  This test is now available to licensed Healthcare Practitioners- to order kits click here.
Read more...

All of the analytical work is performed in our CLIA certified laboratory.
CLIA ID# 07D1091103

News

JS Genetics Chooses XIFIN for Revenue Cycle Management and Commercialization Strategies.More...
JS Genetics receives CAP accreditation from College of American Pathology. More...
JS Genetics presents to Yale & CURE BioHaven Entrepreneurship Series. More...
NICHD approves JS Genetics funding for a NIH Phase 2 Development of Novel Diagnostic More...
Results of XCAT-TS validation Study are published in the Journal of Clinical Endocrinology & Metabolism…More
JS Genetics Develops New Non-Invasive Test, XCAT-TS, to Help Doctors Diagnose Turner Syndrome More...